Abstract. X-inactive specific transcript (XIST), one of the first found cancer-associated long non-coding RNAs (lncRNAs), is involved in the development and progression of many types of tumors. Aberrant expression of XIST has been observed in hepatocellular carcinoma, cervical, breast, ovarian and colorectal cancer. However, the exact effects and molecular mechanisms of XIST in lung cancer progression are still unknown to date. In the present study, we investigated the role of XIST in human lung cancer cell lines and clinical tumor samples in order to determine the function of this molecule. In our research, lncRNA-XIST was specifically upregulated in lung cancer cell lines and promoted lung cancer cell growth through targeting miR-140. Knockdown of XIST inhibited the proliferation and promoted cell apoptosis of human lung cancer cells and suppressed metastasis in vitro and in vivo. In addition, miR-140-dependent inhibitor of apoptosisstimulating protein of p53 (iASPP) regulation was required in XIST-induced lung cancer cell growth. These findings indicated that XIST may regulate the tumor growth and metastasis via miR-140-dependent iASPP regulation. Taken together, our data indicated that XIST may be an oncogenic lncRNA that promotes the proliferation and metastasis of lung cancer through the regulation of miR-140 and could be regarded as a therapeutic target in human lung cancer.
Introduction
Lung cancer is a tumor with a highly malignant phenotype characterized by rapid progression, late diagnosis, and a limited response to radiotherapy and chemotherapy. In the past 10 years, despite of the FDA approved therapeutic regimens and great improvements in medical care, we have observed no momentous effect on lung cancer patient survival (1, 2) . Therefore, to identify biomarkers which may promote early diagnosis and allow personalized treatment strategies for patients at a high risk of lung cancer has become an urgent need (2) .
MicroRNAs (miRNAs) are particularly important in almost all tumor developmental processes since they can be targets of genomic lesions, controlled by classic tumor signals, and they themselves present as a class of oncogenes or tumor suppressors (3, 4) . Recently, a close association between miRNAs and lung cancer tumorigenesis has been suggested (5, 6) . Multiple miRNAs, such as the let-7 family (7), miR-200 (8), miR-486 (9) and miR-146a (10) have been identified as tumor suppressors. Meanwhile, miR-31 (11), miR-212 (12) and miR-196a (13) were found to promote lung cancer carcinogenesis. miR-140 has been noted since it is involved in the development and progression of many types of cancers, including breast cancer (14) , osteosarcoma (15) , colon (16) and lung cancer (17) . Yuan et al reported that miR-140 is significantly downregulated in non-small cell lung cancer (NSCLC) tissues and cell lines; and that miR-140 suppresses tumor growth and metastasis of NSCLC by targeting insulin-like growth factor 1 receptor (18) . These findings suggest that miR-140 plays a tumor-suppressor role in these cancers. However, to the best of our knowledge, its role and the potential mechanisms in lung cancer remain unclear.
Human genome sequence data indicate that more than 90% of the DNA sequences actively transcribe, but only 2% encode protein; thus, the majority of the transcripts are referred to as non-coding RNAs (ncRNAs) (19, 20) . Small non-coding RNAs such as miRNAs have been studied extensively and their roles in gene regulation and cell function have been elucidated in numerous types of cancers (20) . Recent studies have shown that long non-coding RNAs (lncRNAs) play important roles in both normal development and diseases including cancer (21) . LncRNAs have emerged as new players in cancer research and several studies have shown that some lncRNAs function as oncogenes, tumor suppressor genes or both, depending on the circumstance (22) .
The mechanisms by which lncRNAs exert their effect vary under different conditions; however, the interaction between lncRNAs and microRNAs plays a major role (23, 24) . Zhu et al reported that the lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting transforming growth factor β-induced protein (TgFbI) (25) . The interaction between miR-141 and lncRNA-H19 has been regarded as an important component in regulating cell proliferation and migration in gastric cancer (26) .
In the present study, we report an interaction between X-inactive specific transcript (XIST) and miR-140 which regulates lung cancer cell growth by directly targeting inhibitor of apoptosis-stimulating protein of p53 (iASPP). our findings provide a novel understanding of the role of XIST and miR-140 in lung cancer metastasis and the mechanism involved.
Materials and methods
Tissue samples, cell lines and cell transfection. We collected 28 paired primary lung cancer and matched adjacent normal tissues. We obtained all samples from patients who underwent surgical resection at Xiangya Hospital of Central South university (Changsha, China). The tissues were snap-frozen in liquid nitrogen, and then stored at -80̊C. The present study was approved by the ethics Committee of Xiangya Hospital of Central South university. Informed consent statements were obtained from all the subjects included.
We purchased human lung cancer cell lines, A549 and H1299, from the American Type Culture Collection (ATCC; Manassas, VA, uSA). They were cultured in RPMI-1640 medium (Invitrogen, Carlsbad, CA, uSA) supplemented with 10% fetal bovine serum (gibco, Carlsbad, CA, uSA) at 37̊C in a humidified atmosphere with 5% Co 2 . The expression of miR-140 was regulated by transfection of miR-140 mimics or miR-140 inhibitor (genePharma, Shanghai, China) using Lipofectamine 2000 (Invitrogen). A pcDNA3.1/iASPP was used to achieve overexpression of iASPP (geneCopoecia, guangzhou, China). Cells were plated into 6-or 96-well plates, transfected, incubated for 24 or 48 h, and used for further assays or RNA/protein extraction.
RNA extraction and SYBR-Green quantitative PCR analysis.
We extracted total RNA from cells using TRIzol reagent (Invitrogen), and detected mature miR-140 expression in cells using a Hairpin-it™ miRNAs qPCR kit (genePharma). We used expression of RNu6b as an endogenous control. iASPP expression was measured using SYbR-green qPCR assay (Takara, Dalian, China). Data were processed using the 2 -ΔΔCt method.
MTT assay. A modified MTT assay was used to evaluate cell viability. After seeding 2x10 3 transfected cells/well into 96-well culture plates we assessed the viability of A549 and H1299 cells transfected with miR-140 or control at five time points (on day 1-5). In brief, quantification of mitochondrial dehydrogenase activity was achieved through the enzymatic conversion of [3-(4,5-dimethyldiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT); Sigma-Aldrich, St. Louis, Mo, uSA] to a colored formazan product. MTT (10 µl, 10 mg/ml) was added to the cells, incubated for 4 h, and the reaction was terminated by removal of the supernatant and addition of 100 µl dimethyl sulfoxide (DMSo) to dissolve the formazan product. After 0.5 h, the optical density (oD) of each well was measured at 570 nm using a plate reader (eLx808; bio-Tek Instruments, Inc., Winooski, VT, uSA).
BrdU incorporation assay. DNA synthesis in proliferating cells is determined by measuring 5-bromo-2'-deoxyuridine (brdu) incorporation. brdu assays were performed at 24 and 48 h after transfecting A549 and H1299 cells with miR-140 or the control vector. After seeding the infected cells in 96-well culture plates at a density of 2x10 3 cells/well, they were cultured for 24 or 48 h, and incubated with a final concentration of 10 µM brdu (bD Pharmingen, San Diego, CA, uSA) for 2-24 h. When the incubation period ended, we removed the medium, fixed the cells for 30 min at room temperature (RT), incubated them with peroxidase-coupled anti-brdu antibody (Sigma-Aldrich) for 60 min at RT, washed them three times with phosphate-buffered saline (PbS), incubated the cells with peroxidase substrate (tetramethylbenzidine) for 30 min, and measured the absorbance values at 450 nm. background brdu immunofluorescence was determined in cells not exposed to brdu, but stained with the brdu antibody.
Apoptosis cell death detection by enzyme-linked immunosorbent assay (ELISA).
To measure apoptosis in vitro, a DNA-fragmentation eLISA was used according to the manufacturer's instructions (Roche Diagnostics, Indianapolis, IN, uSA).
Western blot analysis. The expression of iASPP and XIST in the lung cancer cells was detected by performing immunoblotting. We lysed cultured or transfected cells in RIPA buffer with 1% phenylmethanesulfonyl fluoride (PMSF), and loaded protein onto a SDS-PAge minigel and transferred them onto polyvinylidene difluoride (PVDF) membranes. After being probed with 1:1,000 diluted rabbit polyclonal iASPP and XIST antibodies (Abcam, Cambridge, MA, uSA) at 4̊C overnight, the blots were subsequently incubated with the HRP-conjugated secondary antibody (1:5,000). eCL substrates were used to visualize signals (Millipore, billerica, MA, uSA). β-actin was used as an endogenous protein for normalization.
Luciferase reporter assay. A549 cells were seeded into a 24-well plate. After being cultured overnight, the cells were co-transfected with the wild-type and mutated iASPP 3' untranslated region (3' uTR) reporter plasmid, and pRL-TK plasmids, or transfected with miR-140 mimics and miR-140 inhibitor. Luciferase assays were performed 48 h after transfection using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI, uSA).
Statistical analysis. Data are expressed as the mean ± SD of three independent experiments and were processed using SPSS 17.0 statistical software (SPSS, Inc., Chicago, IL, uSA). using Wilcoxon's paired test we compared the expression of miR-140 in lung cancer and the paired adjacent normal colonic tissues. The differences between groups were evaluated using the one-way analysis of variance (ANoVA). P-values of <0.05 were considered statistically significant.
Results

miR-140 negatively regulates iASPP expression in the A549 cell line.
SYbR-green quantitative PCR analysis was performed to quantify the expression of miR-140 in lung cancer tissues. In a large panel of 28 cases of primary lung cancer and the adjacent normal colonic tissues, the expression of miR-140 was significantly decreased in the lung cancer tissues, compared with that noted in the paired adjacent normal tissues (Fig. 1A) . In contrast, the expression of iASPP was upregulated in the lung cancer tissues, compared with that noted in the paired adjacent normal tissues (Fig. 1b ). An inverse correlation between the expression levels of miR-140 and iASPP was observed (Fig. 1C) . To investigate the effect of miR-140 on iASPP expression, miR-140 mimics were used to achieve miR-140 overexpression, and miR-140 inhibitor was used to achieve miR-140 knockdown in the A549 and H1299 cell lines (Fig. 1D and e) , and the expression efficiency was verified using real-time PCR. Next, the protein expression of iASPP was determined using western blotting in response to miR-140 overexpression or miR-140 inhibition. Results showed that miR-140 overexpression suppressed the iASPP protein expression, while miR-140 inhibition promoted the iASPP protein expression in both A549 and H1299 cell lines ( Fig. 1F and g ).
iASPP mRNA is a direct target of miR-140. It was predicted that miR-140 could bind to and target the iASPP 3' uTR using TargetScan, miRanda and miRWalk (27) (28) (29) . A wt-iASPP 3' uTR luciferase reporter vector (wt-iASPP) was created to confirm this prediction, as well as a mut-iASPP 3' uTR luciferase reporter vector (mut-iASPP) by sequentially mutating the predicted five base pair miR-140 binding site in the iASPP 3' uTR ( Fig. 2A) . The wt-iASPP vector and miR-140 mimics or inhibitor were co-transfected into the A549 cell line. In the miR-140 mimic-transfected cells, the luciferase activity of the iASPP 3' uTR luciferase reporter vector was significantly reduced while it was induced in the miR-140 inhibitor-transfected cells, compared to the inhibitor NC group (Fig. 2b and C) . However, mutation of the putative the miR-140 binding site in the iASPP 3' uTR abolished miR-140-mediated repression of iASPP 3' uTR luciferase reporter activity ( Fig. 2b and C) .
miR-140 inhibits the proliferation of lung cancer cell line through iASPP.
To investigate the functional roles of iASPP in lung cancer cells, we transfected A549 and H1299 cell lines with pcDNA3.1/iASPP to achieve iASPP overexpression (Fig. 3A) . The expression level of iASPP protein was verified using western blotting (Fig. 3A) . Then, pcDNA3.1/iASPP and miR-140 mimics/mimics NC were co-transfected into the A549 and H1299 cell lines. MTT and brdu results showed that miR-140 mimic transfection significantly reduced the cell proliferation, while the forced expression of iASPP reversed the significant inhibition on cell proliferation by miR-140 ( Fig. 3b and C) . Similarly, miR-140 overexpression notably promoted the DNA fragmentation of both A549 and H1299 cells, while iASPP transfection attenuated the promotive effect of miR-140 on DNA fragmentation of both A549 and H1299 cells (Fig. 3D) .
XIST is correlated with miR-140 by direct targeting.
According to previous studies, miR-140 plays a suppressive role in cancers (30). Previous studies have reported that XIST is associated with cancers by regulating miRNAs (31) . To further investigate the mechanism by which miR-140 is regulated in lung cancer cell lines, we generated a wt-XIST 3' uTR luciferase reporter vector (wt-XIST), as well as a mut-XIST3' uTR luciferase reporter vector (mut-XIST) by sequentially mutating predicted miR-140 binding sites in the XIST 3' uTR (Fig. 4A) . We co-transfected the wt-XIST/mut-XIST vectors and miR-140 NC/miR-140 mimics into A549 cells. The luciferase activity of the XIST luciferase reporter vector was significantly reduced in the miR-140 mimic-transfected cells, compared to the mimics NC groups (Fig. 4b) . Moreover, the luciferase activity of the XIST luciferase reporter vector was markedly amplified in the miR-140 inhibitor-transfected cells, compared to the inhibitor NC groups (Fig. 4C) .
XIST promotes lung cancer cell growth and inhibits cell apoptosis. Next, we investigated the association of XIST expression with lung cancer cell proliferation. XIST knockdown was achieved by si-XIST and the inhibitory efficiency was verified by real-time PCR (Fig. 5A) . Two lung cancer cell lines, A549 and H1299, were transfected with si-NC or si-XIST, and then the cell proliferation was determined by MTT and brdu assays. MTT assays revealed that knockdown of XIST significantly attenuated the proliferation of both A549 and H1299 cell lines over time, compared with the si-NC group (Fig. 5b and C) . Moreover, it was observed that DNA fragmentation of both A549 and H1299 cell lines was significantly promoted (Fig. 5D) . Taken together, these data revealed that lncRNA-XIST promoted lung cancer cell growth and inhibited cell apoptosis.
XIST promotes iASPP expression through miR-140. given that XIST inhibits miR-140 by direct binding, and that miR-140 inhibits iASPP by binding to its 3' uTR, we next investigated the association of XIST expression with iASPP protein expression in lung cancer cell lines. Results from western blotting showed that miR-140 knockdown significantly promoted iASPP protein expression, while XIST knockdown by si-XIST could partly restore this effect in both A549 and H1299 cell lines (Fig. 6A and b) . Taken together, XIST promoted iASPP expression, most possibly through miR-140.
Discussion
Alterations in the presence of miRNAs are implicated in almost all fields of cancer biology, including cell growth, apoptosis, migration and/or invasion, and they function as either tumor suppressors or oncogenes (28) . In the present study, we focused on miR-140 due to its potential suppressive function in human malignances. Song et al indicated that cell proliferation in both osteosarcoma and colon cancer cell lines was inhibited by overexpression of miR-140 (16) . Recently, Yang et al reported that miR-140-5p was significantly decreased in HCC tissues and cell lines, and its overexpression suppressed tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 (32). To date, however, the role of miR-140 in lung cancer carcinogenesis and the molecular mechanisms by which miR-140 exerts its functions remain unclear. In the present study, the real-time PCR results showed that miR-140 expression was significantly downregulated in lung cancer tissues. overexpression of miR-140 significantly inhibited the proliferation and promoted the cell apoptosis of lung cancer cell. Accordingly, knockdown of miR-140 promoted cell proliferation and attenuated cell apoptosis. These results indicate that miR-140 could be a potential tumor-suppressor miRNA in lung cancer.
The impact of specific miRNAs on cancer biology depends on their downstream targets (33, 34) . Different prediction algorithms were used to predict gene targets for miR-140, to elucidate the underlying mechanisms involved in the miR-140-induced inhibition of lung cancer growth and metastasis. The iASPP oncogene was identified as a critical downstream target of miR-140, due to its frequent overexpression in many malignancies and its function as an important regulator of cell proliferation, survival and metastasis (35) (36) (37) (38) . In the present study, miR-140 overexpression significantly downregulated the protein level of iASPP. Meanwhile, knockdown of miR-140 upregulated the expression of iASPP. A luciferase reporter assay validated the binding and repressive effects of miR-140 on the iASPP 3' uTR in A549 cells. Western blot analysis also confirmed that iASPP was downregulated by miR-140 upregulation, and upregulated by miR-140 downregulation. Moreover, the expression levels of miR-140 and iASPP in clinical lung cancer samples were significantly inversely correlated. To further confirm the role of iASPP in the A549 cell line, we revealed that knockdown of iASPP inhibited the proliferation and promoted the apoptosis of the A549 cell line. These data regarding the involvement of the miR-140/iASPP axis in lung cancer suggest that miR-140 may have potential as a therapeutic target.
To identify the correlation between miRNAs and lncRNAs and the underlying mechanisms provide potential targets for tumor treatment. Previous studies have mostly focused on the targets of miRNAs and the mechanisms by which miRNAs regulate the targets, thus as to influence tumor initiation and progression. For example, miRNAs including miR-21, miR-34a, miR-182 (39) (40) (41) , have been reported to be involved in tumor growth and progression. However, few studies have focused on the regulation of miRNAs, particularly the co-regulation of miRNAs by non-coding RNAs. emerging evidence has revealed that the mutual regulation between miRNAs and lncRNAs play major roles in tumor progression. In the present study, we revealed the interaction between XIST and miR-140 for the first time. The knockdown of XIST upregulated miR-140, while forced miR-140 overexpression inhibited the expression of XIST.
To detect the role of XIST in lung cancer cell growth regulation, siRNA was transfected into lung cancer cell lines to knock down XIST. As expected, iASPP was downregulated by XIST knockdown. In addition, the proliferation of lung cancer cell lines was reduced by iASPP inhibition. According to previous studies, iASPP is an oncogene and promotes cancer cell growth (36, 37, 42) .
To further validate the correlation of XIST, miR-140 and iASPP in lung cancer tissues, the expression levels of XIST, miR-140 and iASPP were determined. The data showed that the expression levels of XIST and iASPP were upregulated, while miR-140 expression was downregulated.
In summary, through targeting iASPP, lung cancer cell viability and proliferation were inhibited while cell apoptosis was promoted by miR-140. These effects were due to the regulation of miR-140 by XIST. The XIST/miR-140/iASPP axis identified in the present study may play a key role in regulating lung cancer cell proliferation and apoptosis, and may provide a potential therapeutic strategy for lung cancer.
